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Graves’ disease (GD) is the paradigm of an anti-receptor
autoimmune disease with agonistic auto-antibodies
against the thyrotropin receptor (TSHR) being the
underlying pathogenic mechanism. TSHR belongs to the
category of tissue-restricted antigens (TRAs), which are
expressed by medullary thymic epithelial cells (mTECs)
and thereby induce central T cell tolerance. In order to
understand the association between TSHR gene poly-
morphisms and GD we tested the hypothesis that TSHR
gene variants affect susceptibility to GD by influencing
levels of TSHR transcription in the thymus. The results
indicate that thymic glands from normal children homo-
zygous for the rs179247 predisposing allele of TSHR had
significantly fewer TSHR mRNA transcripts than car-
riers of the protective allele. In addition, in heterozy-
gous, the TSHR predisposing allele was expressed at a
lower level than the protective one as demonstrated by
Allele Specific Transcript Quantification. The effect of
TSHR SNP rs179247 was thymus-specific and not
observed in thyroid glands. These results constitute first
evidence for the involvement of central tolerance in the
loss of tolerance to TSHR in GD and underscore the
concept that variable expression levels of major target
autoantigens in the thymus influence the predisposition
to autoimmunity presumably by changing the threshold
of tolerance.
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